DHL Group and Cryoport (CYRX) are pleased to announce that DHL has acquired 100% of Cryopdp, a specialty courier focused on clinical trials, biopharma, and cell and gene therapies. In this context, the companies also announced a strategic partnership to strengthen their supply chain service offerings for the global life sciences and healthcare sector. The deal and the outlined partnership are subject to regulatory approvals.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CYRX:
- CryoPort Sells CRYOPDP to DHL for $138 Million
- Cryoport price target lowered to $10 from $11 at Guggenheim
- Cryoport upgraded to Buy from Neutral at UBS
- CryoPort’s Mixed Performance and Sector Uncertainties Justify Hold Rating
- CryoPort’s Stabilization Amid Market Uncertainties: A Hold Rating Analysis